Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets ; volume:24 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-8 ; date:12.2018
Molecular medicine ; 24, Heft 1 (15.3.2018), 1-8, 12.2018
- Urheber
-
Izzo, Antonella
- Beteiligte Personen und Organisationen
-
Mollo, Nunzia
Nitti, Maria
Paladino, Simona
Calì, Gaetano
Genesio, Rita
Bonfiglio, Ferdinando
Cicatiello, Rita
Barbato, Maria
Sarnataro, Viviana
Conti, Anna
Nitsch, Lucio
SpringerLink (Online service)
- DOI
-
10.1186/s10020-018-0004-y
- URN
-
urn:nbn:de:1111-20180528854
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Izzo, Antonella
- Mollo, Nunzia
- Nitti, Maria
- Paladino, Simona
- Calì, Gaetano
- Genesio, Rita
- Bonfiglio, Ferdinando
- Cicatiello, Rita
- Barbato, Maria
- Sarnataro, Viviana
- Conti, Anna
- Nitsch, Lucio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells
FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells
HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis
Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells
FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells
HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis
Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells
FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells
HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis
Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives